PROGENICS PHARMACEUTICALS IN - COM (PGNX)

CUSIP: 743187106

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
47,435,426
Share change
-58,430
Total reported value
$253,006,719
Put/Call ratio
204%
Price per share
$5.33
Number of holders
70
Value change
-$311,247
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 743187106?
CUSIP 743187106 identifies PGNX - PROGENICS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROGENICS PHARMACEUTICALS IN - COM (PGNX) as of Q4 2013

As of 31 Dec 2013, PROGENICS PHARMACEUTICALS IN - COM (PGNX) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,435,426 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, FMR LLC, BAKER BROS. ADVISORS LP, Broadfin Capital, LLC, TUDOR INVESTMENT CORP ET AL, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, HIGHLAND CAPITAL MANAGEMENT LP, and State Street Corp. This page lists 70 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.